Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AkPharma develops, markets, and licenses health-related products based on calcium glycerophosphate. Its best-known commercial product is "Prelief", an OTC dietary supplement aimed at reducing acid in foods to help people with bladder sensitivity. The company has sponsored or conducted clinical studies on calcium glycerophosphate nasal sprays for allergic rhinitis, topical formulations for wound healing/scar reduction after surgery, and other dermatological/urological uses. It collaborates with academic institutions such as Drexel University. There are no late-stage pharmaceutical assets; its focus remains on consumer health/dietary supplements with some medical device/topical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AkPharma.